Last deal

$15M

Amount

Post-IPO Equity

Stage

19.12.2016

Date

3

all rounds

$82.5M

Total amount

General

About Company
Lombard Medical develops and markets minimally invasive abdominal aortic aneurysm endovascular repair products.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Anson Medical

founded date

01.01.1994

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The medical technology company specializes in developing, manufacturing, and marketing endovascular stent-grafts, including Aorfix, IntelliFlex, and Altura Endovascular Stent Graft System, which address significant unmet needs in the repair of aortic aneurysms. Lombard Medical's products are designed for patients with aortic neck angulations from 0 to 90 degrees. The company generates the majority of its revenue from Japan.